Description of the blood test: 

The EBNA IgG test is a laboratory study used to detect antibodies against the nuclear antigen of the Epstein-Barr virus (EBV). These antibodies are produced in the late stages of the infection, usually appearing 2 to 4 months after the initial onset, and remain in the blood for life. In clinical diagnostics, this indicator serves as a “marker of immunity,” helping the physician confirm that the body has already encountered the virus and has moved past the acute phase into a period of long-term carrier status.

What does the analysis represent?

• Purpose: Quantitative or qualitative determination of IgG antibodies to the nuclear antigen (EBNA) of EBV in the blood serum.
• Primary application: Confirmation of a past infection, differential diagnosis of chronic fatigue syndrome, and assessment of immune status.
• Performance: High-precision enzyme immunoassay (ELISA) of a venous blood sample.

Recommendations for the test (General)

• Time: Blood collection is recommended during the morning hours.
• Fasting: It is necessary to observe a food intake pause of 4–8 hours before the procedure.
• Rest: It is important to spend at least 15–30 minutes in a calm, seated position immediately before the procedure.
• Important: This test is usually negative during the first weeks of an acute illness; it only becomes positive once the infection is resolved.

What can affect the results?

• False-positive results: Occasionally possible due to cross-reactivity with other herpes-family viruses or certain autoimmune processes.
• False-negative results: Possible in the early months following infection before the immune system has fully produced these specific nuclear antibodies.

When to take the test?

• Recommendations: The test is prescribed when evaluating a history of infectious mononucleosis, investigating the causes of prolonged lymphadenopathy (swollen nodes), or evaluating chronic fatigue.
• Preparation: Standard preparation for serological tests; exclude alcohol and heavy food 24 hours before the analysis.

How to interpret the results?

The interpretation of data is the exclusive responsibility of an infectious disease specialist or an immunologist. The value of EBNA IgG is never a definitive diagnosis on its own. The physician analyzes the indicator by correlating it with other EBV markers (like VCA IgM or VCA IgG) and the patient’s clinical history. Only an expert approach allows for the differentiation between a past infection, a latent state, or a potential reactivation, ensuring the correct management plan is established.

Possible further research

• VCA IgG and VCA IgM: To determine the specific phase of the virus (acute vs. past).
• Complete Blood Count (CBC): To monitor lymphocyte levels and general immune response.
• Consultation with a Neurologist: To evaluate neurological health if the virus is suspected of affecting the nervous system.
• EBV PCR: To detect the presence of the virus DNA in the blood.

When does the next step make sense?

Upon receiving a positive result, it confirms you are a carrier of the virus with established immunity. If symptoms persist, the next step involves a professional consultation to determine if the virus is a contributing factor or if further diagnostic steps are needed to ensure long-term well-being.

👉 If necessary, you can discuss the test results with our specialized — neurologist (Doctors – TAMC)